Opko Health (OPK) Cash from Financing Activities (2016 - 2025)
Opko Health (OPK) has disclosed Cash from Financing Activities for 16 consecutive years, with -$18.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities rose 54.69% year-over-year to -$18.3 million, compared with a TTM value of -$118.1 million through Dec 2025, down 164.1%, and an annual FY2025 reading of -$118.1 million, down 164.1% over the prior year.
- Cash from Financing Activities was -$18.3 million for Q4 2025 at Opko Health, down from -$16.2 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $206.1 million in Q3 2024 and bottomed at -$79.5 million in Q2 2025.
- Average Cash from Financing Activities over 5 years is $3.4 million, with a median of -$2.9 million recorded in 2023.
- The sharpest move saw Cash from Financing Activities surged 9692.87% in 2024, then crashed 3658.35% in 2025.
- Year by year, Cash from Financing Activities stood at $833000.0 in 2021, then surged by 1117.77% to $10.1 million in 2022, then plummeted by 136.98% to -$3.8 million in 2023, then crashed by 978.97% to -$40.5 million in 2024, then soared by 54.69% to -$18.3 million in 2025.
- Business Quant data shows Cash from Financing Activities for OPK at -$18.3 million in Q4 2025, -$16.2 million in Q3 2025, and -$79.5 million in Q2 2025.